On 20 October 2026, China Health Group Limited (carrying on business in Hong Kong as CHG HS Limited) released an updated register of its Board members and committee assignments.

The Board now consists of eight directors: • Executive Directors – Mr. Cao Xu, Mr. Chung Ho and Ms. Ying Rensi. • Non-Executive Directors – Mr. Ying Wei and Mr. Huang Lianhai. • Independent Non-Executive Directors – Mr. Wu Hui, Mr. Li Hongyi and Ms. Jiang Li.

Committee structures are as follows: • Audit Committee – chaired by Independent Non-Executive Director Mr. Wu Hui, with Mr. Li Hongyi and Ms. Jiang Li as members. • Nomination Committee – chaired by Executive Director Mr. Cao Xu, joined by Mr. Ying Wei, Mr. Wu Hui, Mr. Li Hongyi and Ms. Jiang Li. • Remuneration Committee – chaired by Independent Non-Executive Director Ms. Jiang Li, with Mr. Ying Wei, Mr. Wu Hui and Mr. Li Hongyi serving alongside.

The updated governance framework indicates a balanced mix of executive, non-executive and independent oversight across key committees, positioning the company to meet prevailing corporate governance standards.